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on new substances ill ou r own skin. Recently we have injected other 
peptides in t raderma lly and found vasoactive in testinal polypeptide 
(V IP) as potent as SP [2'1. bu t in no case any sign of systemic reactions 
appeared. 
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B INDING OF BULLOUS PEMPHIGOID ANTIBODIES TO 
BASAL CELLS 
T o the Editor: 
Takeji Nishikawa a nd his associates repor t on the co-existence of 
autoantibodies to the basement membrane zone and the "basa l cell 
membrane a nd/or cytoplasm" in 8 of 12 sera from patients with bullous 
pemphigoid [11. On the basis of this observation and some blocking 
immunoflu orescence studies, the authors conclude that these represent 
2 types of pemphigoid antibodies and that the basal cell antibodies 
cross react wi th pemphigus ant ibodies. 
We do agree that basal ce ll a nt ibodies commonly co-exist with 
pemphigo id ant ibodies. Severa l li terature reports on the basal ce ll 
ant ibodies [21 indicate that they ru'e also found occasionally in the 
normal human sera a nd that they occur more commonly following 
t rauma to the skin; that is, in sera of patients who have suffe red severe 
burns, gra ft vs. host reactions, malignancies, drug reactions, pemphigus, 
and pemphigoid . These findings point to a lack of disease specificity of 
these antibodies which stands in contrast with the basement membrane 
zone antibodies of pemphigoid. Another difference between the basal 
cell ant ibodies and the basement membrane zone antibodies of pem-
phigoid is that the latter appear to bind to n.ormal skin in uiuo [3] whi le 
the basal ce ll ant ibodies fail to do so. 
Takeji Nishikawa and his associates give 2 alternate explanations for 
the localization of the basal cell ant ibodies, i. e. , "basement mem brane 
and/or cytoplasm." The picture of the indirect immunoflu orescence 
reaction patte rn of such basal ce ll antibodies as shown in the i.r Figure 
reveals unstained spaces between some of the basal cells, thus indicating 
that the reactive a ntigen(s) occur inside the cell at the periphery of the 
cytoplasm. This observation favors the second of the 2 alte rnate in ter-
pretations by T a keji Nishikawa et a t. ; t hey do not appear to be 
antibodies to the membranes of basal cells. This also affords a reason-
a ble explanation for the failure of these antibodies to bind in u£uo to 
their ant igen in normal skin. 
Considering the 3 a bove- listed di fferences between the basal ce ll 
ant ibodies and the basement membrane zone antibodies of pemphigoid, 
(notably the differences in their disease specificity, capacity to react in 
uiuo and histologic localization) we suggest an alternative explanation 
for the inte resting lindings of Takeji Nishikawa and his associates [1], 
notably that the re are 2 distinct, unrelated antibodies which do, as the 
authors state, frequently co-exist with basement membrane zone ant i-
bodies. We submit further that these 2 types of autoantibodies serve as 
examples of two distinct types of autoimmunity [4]. 
Another interesting finding of these authors is that pre-treatment of 
frozen tissue sections with sera containing the basal cell and basement 
membrane zone a ntibodies greatly reduced the staining by FITC la-
beled intercellular antibodies while pre-treatment with sera containing 
only basement membrane zone antibodies failed to do so [1]. T he 
authors interpret this to mean that there is some cross reactivity 
between pemphigus antibodies and bullous pemphigoid ant ibodies. 
Blocking immunofluorescence studies with FITC la beled pemphigus 
ant ibodies performed in this laboratory [5] showed that some normal 
human sera could block the 'binding of labeled pemphigus a ntibodies 
just as well as sera of pemphigus patients while the IgG fract ions of 
norma l sera fa iled to do so. Thus, immunoglobulin fractions, not whole 
sera, were deemed to be acceptable for blocking IF studies. T hese 
observations raise 2 in te resting questions a bout the blocking immuno-
tluol'escence s tudies of T a keji Nishikawa et a t. , notably: (1) if 20 or 
more normal sera were tested in such a b locking study, would they all 
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be negative? a nd (2) if the immunoglobulin fractions of sera with 
basement membrane zone ant ibodies wi th and without basal ce ll anti-
bodies were used for these blocking studies would they give the same 
re 'ul ts as the whole sera? T he lindings of Takej i Nishikawa and hi 
associates [ 11 clearly mer it further studies. 
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REPLY 
We are somewhat embru'l'assed to have the comments from Krasny 
et ai, because the in terpretation of our experimental results is com-
pletely different from the basic point [1]. Our interpretation is not the 
co-existence of 2 distinct a nt ibodies but quantitative difference of 
reactivity by basement membrane zone (BMZ) ant ibodies in pemphi-
goid sera. As far as we can understand from the staining pattern, there 
is a cont inuity of a ntigenic substance from the BMZ to the lower 
epidermal cells, as visualized by complement immunofluorescence only. 
Reg31'ding 2 questions a bout the blocking immunofluorescence stud-
ies, we, too, found most undilu ted normal human sera (NHS) could 
block the subsequent binding of FITC labeled inte rcellular antibodies 
(unpublished data). The same result could be obtained, when indirect 
immunofluorescent staining was applied to the skin substrate treated 
wi th undiluted NHS. However , NHS at 1:10 or more dilu t ions did not 
give any blocking of the subsequent staining of intercellular antibodies. 
We interprete this phenomenon as t he direct effect of undilu ted NHS 
[2] or the buffer [3] to the labile intercellular antigen(s) of the epider-
mis. We do not believe this experience of interceUul31' substance is 
applicable to the case of BMZ, since the antigenic property of in tercel-
lular substance and BMZ is lru'gely different. As shown in the Table III 
of our paper [1], the serum dilution of BP sera and that of the control 
NHS' was 1:10 d ilu t ion, where no such blocking effect of ·the serum to 
the skin substrate was shown. 
We obtained the most. purified IgG fraction from T.H. serum [1] by 
(NH., hSO., treatment and G-200 column chromatography and found 
that this purilied IgG at 7 units could block the subsequent binding of 
FITC labeled T .Y. at 2 un its. Al though more sera should be tested to 
draw the delini te conclusion, it seems as if our findings could be 
justified . 
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